Glass House Brands (GLAS) Common Equity (2020 - 2026)

Glass House Brands' (GLAS) quarterly Common Equity came in at $76.9 million in Q1 2026, down 55.96% year-on-year from $174.6 million in Q1 2025, and up 3.97% on a QoQ basis from $73.9 million in Q4 2025.

Glass House Brands (GLAS) Common Equity (2020 - 2026) Analysis & Trends

Glass House Brands (GLAS) has 7 years of Common Equity data on file, last reported at $76.9 million in Q1 2026.

  • On a quarterly basis, Common Equity fell 55.96% year-over-year to $76.9 million in Q1 2026; TTM through Mar 2026 was $76.9 million, a 55.96% decrease from a year earlier, with the FY2025 full-year figure at $73.9 million, down 36.39% from the prior year.
  • Common Equity for Q1 2026 stood at $76.9 million, up from $73.9 million in the prior quarter.
  • Over the last five years, Common Equity for GLAS reached as high as $192.3 million in Q2 2025 and fell as low as $73.9 million in Q4 2025.
  • Historically, Common Equity has averaged $142.4 million across 5 years, with a median of $159.5 million in 2023.
  • Across the five-year window, Common Equity soared 799.93% in 2022 and tumbled 55.96% in 2026, its largest moves.
  • Year by year, Common Equity stood at $168.9 million in 2022, then tumbled by 46.84% to $89.8 million in 2023, then rose by 29.49% to $116.2 million in 2024, then slumped by 36.39% to $73.9 million in 2025, then grew by 3.97% to $76.9 million in 2026.
  • Per Business Quant data, the three most recent Common Equity figures were $76.9 million in Q1 2026, $73.9 million in Q4 2025, and $81.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - 21.93 Bn
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 8.23 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 3.23 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 47.38 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 5.90 Bn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - 4.27 Mn
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 14.66 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 3.41 Bn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 6.50 Bn
10 Glass House Brands 873.84 Mn 845.91 Mn 10.02 Mn 76.87 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 76.87 Mn
Dec 31, 2025 73.94 Mn
Sep 30, 2025 81.38 Mn
Jun 30, 2025 192.32 Mn
Mar 31, 2025 174.56 Mn
Dec 31, 2024 116.24 Mn
Sep 30, 2024 149.73 Mn
Jun 30, 2024 146.68 Mn
Mar 31, 2024 128.40 Mn
Dec 31, 2023 89.76 Mn
Sep 30, 2023 171.03 Mn
Jun 30, 2023 159.47 Mn
Mar 31, 2023 186.87 Mn
Dec 31, 2022 168.86 Mn
Sep 30, 2022 177.01 Mn
Jun 30, 2022 164.79 Mn
Mar 31, 2022 162.96 Mn
Dec 31, 2021 182.13 Mn
Sep 30, 2021 192.85 Mn
Jun 30, 2021 168.14 Mn